Elite Pharmaceuticals, Inc. Amortization of Debt Discount (Premium)
Elite Pharmaceuticals, Inc. (ELTP) reported Amortization of Debt Discount (Premium) of $3.54 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-13
- Elite Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2026-06-30 was $3.54K, a 0.03% decline year-over-year.
- Elite Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2026-03-31 was $3.54K, a 0.03% decline year-over-year.
- Elite Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2025-12-31 was $3.54K, a 0.03% increase year-over-year.
- Elite Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2025-09-30 was $3.54K, a 0.03% decline year-over-year.
- Elite Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2026 was $14.18K, a 0.00% change from fiscal 2025.
- Elite Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2025 was $14.18K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.54K 10-Q · filed 2026-08-13 | $7.09K derived: sum of 2 quarters · filed 2026-08-13 | $10.63K derived: sum of 3 quarters · filed 2026-08-13 | $14.18K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $3.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $7.09K derived: sum of 2 quarters · filed 2026-06-29 | $10.63K derived: sum of 3 quarters · filed 2026-06-29 | $14.18K 10-K · filed 2026-06-29 |
| 2025-12-31 | $3.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | $7.09K derived: sum of 2 quarters · filed 2026-02-17 | $10.63K 10-Q · filed 2026-02-17 | $14.18K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $3.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $7.09K 10-Q · filed 2025-11-14 | $10.63K derived: sum of 3 quarters · filed 2026-08-13 | $14.18K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $3.54K 10-Q · filed 2026-08-13 | $7.09K derived: sum of 2 quarters · filed 2026-08-13 | $10.63K derived: sum of 3 quarters · filed 2026-08-13 | $14.18K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $3.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $7.09K derived: sum of 2 quarters · filed 2026-06-29 | $10.63K derived: sum of 3 quarters · filed 2026-06-29 | $14.18K 10-K · filed 2026-06-29 |
| 2024-12-31 | $3.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | $7.09K derived: sum of 2 quarters · filed 2026-02-17 | $10.63K 10-Q · filed 2026-02-17 | |
| 2024-09-30 | $3.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $7.09K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $3.54K 10-Q · filed 2025-08-14 |